An updated network meta-analysis of egfr-tkis and combination therapy in the first-line treatment of advanced egfr mutation positive non-small cell lung cancer

HIGHLIGHTS

• who: Yuexiao Qi from the Sun Yat-sen University Cancer Center (SYSUCC), China have published the paper: An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer, in the Journal: (JOURNAL) of December/31,/2021
• what: Among them, 62 studies were excluded for the following reasons: 15 studies lacked outcomes of interest, 14 studies were just trial protocols (study designs) without study results, 14 studies referred to second-line treatments; 10 studies were single-arm studies, five trials included . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.